107 related articles for article (PubMed ID: 11337186)
1. Comparative serum bactericidal activity of clarithromycin and azithromycin against macrolide-sensitive and resistant strains of Streptococcus pneumoniae.
Stein GE; Schooley S
Diagn Microbiol Infect Dis; 2001 Mar; 39(3):181-5. PubMed ID: 11337186
[TBL] [Abstract][Full Text] [Related]
2. Comparison of bactericidal activity after multidose administration of clarithromycin, azithromycin, and ceruroxime axetil against Streptococcus pneumoniae.
Lacy MK; Owens RC; Xu X; Nicolau DP; Quintiliani R; Nightingale CH
Int J Antimicrob Agents; 1998 Nov; 10(4):279-83. PubMed ID: 9916901
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity and pharmacodynamics of azithromycin and clarithromycin against Streptococcus pneumoniae based on serum and intrapulmonary pharmacokinetics.
Kays MB; Denys GA
Clin Ther; 2001 Mar; 23(3):413-24. PubMed ID: 11318076
[TBL] [Abstract][Full Text] [Related]
4. Serum bactericidal activity of extended-release clarithromycin against macrolide-resistant strains of Streptococcus pneumoniae.
Stein GE; Schooley S
Pharmacotherapy; 2002 May; 22(5):593-6. PubMed ID: 12013358
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of twenty penicillin-susceptible and -resistant pneumococci to levofloxacin, ciprofloxacin, ofloxacin, erythromycin, azithromycin, and clarithromycin by MIC and time-kill.
Visalli MA; Jacobs MR; Appelbaum PC
Diagn Microbiol Infect Dis; 1997 Jul; 28(3):131-7. PubMed ID: 9294703
[TBL] [Abstract][Full Text] [Related]
6. Antipneumococcal activities of two novel macrolides, GW 773546 and GW 708408, compared with those of erythromycin, azithromycin, clarithromycin, clindamycin, and telithromycin.
Matic V; Kosowska K; Bozdogan B; Kelly LM; Smith K; Ednie LM; Lin G; Credito KL; Clark CL; McGhee P; Pankuch GA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2004 Nov; 48(11):4103-12. PubMed ID: 15504828
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of antimicrobial and bactericidal activities and postantibiotic effects of macrolides antibiotics against clinical isolates, and examination of shape alteration by scanning electron microscope].
Yano H; Kobayashi T; Okitsu N; Aoki A; Toriya M; Nakada Y; Sagai H; Iyobe S; Inoue M
Jpn J Antibiot; 2007 Feb; 60(1):31-46. PubMed ID: 17436861
[TBL] [Abstract][Full Text] [Related]
8. Comparative activities of clarithromycin, erythromycin, and azithromycin against penicillin-susceptible and penicillin-resistant pneumococci.
Ednie LM; Visalli MA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1996 Aug; 40(8):1950-2. PubMed ID: 8843313
[TBL] [Abstract][Full Text] [Related]
9. Influence of macrolide susceptibility on efficacies of clarithromycin and azithromycin against Streptococcus pneumoniae in a murine lung infection model.
Hoffman HL; Klepser ME; Ernst EJ; Petzold CR; Sa'adah LM; Doern GV
Antimicrob Agents Chemother; 2003 Feb; 47(2):739-46. PubMed ID: 12543686
[TBL] [Abstract][Full Text] [Related]
10. Serum bactericidal activity of gemifloxacin versus clarithromycin against Streptococcus pneumoniae with different susceptibility to quinolones.
Malerczyk C; Kolbert M; Kinzig-Schippers M; Sörgel F; Machka K; Shah PM
J Chemother; 2004 Feb; 16(1):56-61. PubMed ID: 15078000
[TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamic activity of azithromycin against macrolide-susceptible and -resistant Streptococcus pneumoniae simulating clinically achievable free serum, epithelial lining fluid and middle ear fluid concentrations.
Zhanel GG; DeCorby M; Noreddin A; Mendoza C; Cumming A; Nichol K; Wierzbowski A; Hoban DJ
J Antimicrob Chemother; 2003 Jul; 52(1):83-8. PubMed ID: 12775677
[TBL] [Abstract][Full Text] [Related]
12. The activity of 14-hydroxy clarithromycin, alone and in combination with clarithromycin, against penicillin- and erythromycin-resistant Streptococcus pneumoniae.
Martin SJ; Garvin CG; McBurney CR; Sahloff EG
J Antimicrob Chemother; 2001 May; 47(5):581-7. PubMed ID: 11328768
[TBL] [Abstract][Full Text] [Related]
13. Kinetic bactericidal activity of telithromycin, azithromycin and clarithromycin against respiratory pathogens.
Drago L; De Vecchi E; Nicola L; Legnani D; Gismondo MR
APMIS; 2005 Oct; 113(10):655-63. PubMed ID: 16309423
[TBL] [Abstract][Full Text] [Related]
14. Selection of resistance of telithromycin against Haemophilus influenzae, Moraxella catarrhalis and streptococci in comparison with macrolides.
Drago L; De Vecchi E; Nicola L; Colombo A; Gismondo MR
J Antimicrob Chemother; 2004 Aug; 54(2):542-5. PubMed ID: 15215227
[TBL] [Abstract][Full Text] [Related]
15. Microbiologic activity of the newer macrolide antibiotics.
McCracken GH
Pediatr Infect Dis J; 1997 Apr; 16(4):432-7. PubMed ID: 9109155
[TBL] [Abstract][Full Text] [Related]
16. Incidence of antibiotic-resistant Streptococcus pneumoniae and beta-lactamase-positive Haemophilus influenzae in clinical isolates from patients with otitis media.
McLinn S; Williams D
Pediatr Infect Dis J; 1996 Sep; 15(9 Suppl):S3-9. PubMed ID: 8878239
[TBL] [Abstract][Full Text] [Related]
17. In vitro selection of resistance to clarithromycin in Streptococcus pneumoniae clinical isolates.
Drago L; De Vecchi E; Nicola L; Legnani D; Prenna M; Ripa S
J Chemother; 2005 Apr; 17(2):161-8. PubMed ID: 15920900
[TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamic target attainment potential of azithromycin, clarithromycin, and telithromycin in serum and epithelial lining fluid of community-acquired pneumonia patients with penicillin-susceptible, intermediate, and resistant Streptococcus pneumoniae.
Noreddin AM; El-Khatib WF; Aolie J; Salem AH; Zhanel GG
Int J Infect Dis; 2009 Jul; 13(4):483-7. PubMed ID: 19046911
[TBL] [Abstract][Full Text] [Related]
19. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae.
Mazzariol A; Koncan R; Vitali LA; Cornaglia G
J Antimicrob Chemother; 2007 Jun; 59(6):1171-6. PubMed ID: 17405779
[TBL] [Abstract][Full Text] [Related]
20. [Antimicrobial activities of macrolides against recent clinical isolates, and analysis of resistant mechanisms].
Okubo T; Iyobe S; Fujiki Y; Sagai H
Jpn J Antibiot; 2003 Jun; 56(3):163-70. PubMed ID: 12942787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
